Our Blog

Monday, 11 March 2019 16:56

RAFI TONE innovation survey case study

Published in Case Studies

Asthma is the most common lung condition in children in the UK, affecting around 1 in 11 children. Although there is no cure for asthma, it can usually be controlled through the use of medications which are normally in the form of an inhaled substance.

For good asthma control, regular reviews with a healthcare practitioner specialising in asthma are recommended. It is also essential that children learn good inhaler technique and take their medication as directed by their healthcare practitioner (HCP).

Clin-e-Cal Limited has developed an app, RAFI TONE, to help young children with asthma to accept a spacer with face mask and to help children and their carers to understand good inhaler technique. The app works with the Clement Clarke Able Spacer device which features a whistle mask. The app recognises the tone of the whistle mask; driving a series of simple games aimed at young children. Only good technique will make the game work.

The challenge

To develop an innovation survey in the Salford area to determine if use of the RAFI TONE / Able spacer innovation has a positive impact on patient care in terms of improving asthma control, aiding communication of good inhaler technique with parents and children and reducing demand for additional healthcare intervention such as visits to A&E.

Customer Testimonial

“Working with Accelerate was made exceptionally easy. Philippa and Katherine were quick to pick up the brief and provided valuable input into the project design at all stages to enable us to derive the best value from the work. We found Accelerate to be thoroughly professional and flexible in the way that they work and interact and I would highly recommend their services to anyone seeking input for a bespoke market assessment project.” Lizzie Crawford, Managing Director, Clin-e-cal Limited.

The approach

Accelerate Associates was contracted to develop questionnaires for parents and carers of young children with asthma and healthcare practitioners involved in the management of asthma. The questionnaires were disseminated by a specialist Respiratory consultancy. Accelerate subsequently collated all the innovation survey data and produced the project report.


More than 100 patients used the RAFI TONE / Able spacer innovation with their parents completing baseline and follow up surveys. A total of 13 general practices across the Salford CCG area participated in the survey and feedback was collated from the HCPs responsible for the care of the survey patients.

The feedback obtained enabled a wealth of positive information to be reported back to the CCG including patients’ feelings about taking their inhaler, carers’ confidence in delivering inhaler medication, and the improved communication between nurses and patients about effective inhaler technique.    

Published in Marketing

What sets Accelerate apart from most marketing organisations is our first hand product management experience in the laboratory supplies and medical devices markets. Specifically, we have been at the coalface of identifying unmet needs in the market and then developing, manufacturing and marketing new products into markets that include: Packaging, medical devices, laboratory consumables, food supplements and emergency medical equipment. 

Both Katherine and I regularly draw on experiences gained in our early days at Bibby Sterilin Limited; developing and marketing products in the laboratory consumables market. There are not a huge number of marketing consultants that know one end of a Husky injection moulding machine from the other.

In addition to working with all things polyethylene, polystyrene and silicone rubber (!), among the team we have experience in supplying the emergency services in the US and UK, the food supplements industry, packaging (bottles, caps and closures) and even how to best bronze the world's strongest man - but that is a story for another day.

Perhaps best known for our work with early stage medical devices, we are acutely aware of the challenges that lie ahead in the healthcare market and also the potential for exciting innovation to help provide the strategies the world will need to deliver effective, efficient healthcare to an ageing population.

Founded in research that we have undertaken over the last decade, we truly believe that the medical technology market is ripe for innovation and we would hope to see some segments of the market take significant steps forward this year such as the use of gamification in rehabilitation.

Wednesday, 30 July 2014 09:45

Why we love working with MedTech SME's

Published in Market Research

There are around 3,000 companies in the UK MedTech market, of which the majority of them are   SMEs. Integral to this market are academic researchers, NHS clinicians, scientists, engineers and inventors resulting in an ecosystem that is ripe for innovation.

Start-ups play a significant role in this market. Specialising in early stage medical technology assessments means that Accelerate Associates is often privileged to work with young companies that plan to introduce a new medical technology into the market, have a disruptive technology or have developed a lifesaving – or changing idea.

From a market research perspective, this is a challenging and exciting market to work in. With the UK MedTech market now the sixth largest in the world, and the third largest in Europe, it is clear that UK MedTech SMEs are leading the way to improved healthcare systems and patient outcomes.


Blog Authors

Partnerships & Affiliations

Chartered Marketeer


Founded in 2007, Accelerate Associates is a specialist business-to-business marketing agency providing marketing and market research for science and medical technologies... More...


Suite D, Reward House
Diamond Way, Stone Business Park 
Stone, Staffordshire, ST15 0SD

Phone: 01785 747 102

This email address is being protected from spambots. You need JavaScript enabled to view it.


Subscribe to our newsletter to receive an e-mail every now and again with all the latest Accelerate news.

Click here to subscribe